Decision Support · Side-by-side
Compare pricing, strengths, and use cases so it is easier to pick the right fit.
Change tools
Neither ConcertAI nor Luna DNA is built for everyday users — these are specialized enterprise and research tools. ConcertAI wins for large biotech firms needing FDA-grade oncology data and clinical trial optimization, while Luna DNA is better for researchers and individuals wanting to contribute genomic data to community-owned studies. The single biggest difference: ConcertAI is a high-cost, high-complexity platform for professionals, whereas Luna DNA is a consent-driven, research-focused data pool.
ConcertAI
Luna DNA
Scores at a glance
Choose ConcertAI if
Choose Luna DNA if
Key differences
Facts side by side
| ConcertAI | Luna DNA | |
|---|---|---|
| Free plan | ||
| Mobile app | ||
| API access |
Common questions
No. Neither tool has a mobile app. Both are accessed via desktop web portals.
Neither is ideal. ConcertAI is too expensive and complex for small teams. Luna DNA is not designed for drug development — it's a research data pool.
No. 23andMe gives you personal ancestry and health reports. Luna DNA is a research platform where you contribute your data to studies — you don't get personal reports back.
No. ConcertAI is for enterprise life sciences use, not for individuals. It requires institutional data and clinical expertise.
Both are HIPAA/GDPR compliant. Luna DNA's community-owned model gives you more direct control over consent and data use.
ConcertAI is a powerful but expensive enterprise oncology platform; Luna DNA is a community-driven genomic research tool — neither is for everyday consumers.
If you're a regular person, skip both — they're not built for you. If you're a researcher or a large biotech firm, Luna DNA is the more accessible, ethical choice for genomic research, while ConcertAI is the heavy-duty option for oncology drug development.
